Home › Funds › Soleus Capital Management, L.P. › VCEL
Soleus Capital Management, L.P. position in VCEL
VERICEL CORP · Health Care
Soleus Capital Management, L.P. reported holding 1,459,152 shares of VCEL (VERICEL CORP) in its Q2 2026 13F filing — a position valued at US$64.9M, representing 2.24% of its reported portfolio and ranking #11 among its reported holdings. Soleus Capital Management, L.P. has disclosed VCEL holdings in 6 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s VCEL position evolved
Soleus Capital Management, L.P. first disclosed a stake in VCEL in Q4 2024 at 80,696 shares (US$4.4M). The position peaked in Q1 2026 at 2,549,079 shares, worth US$82.0M. Across 6 filings, Soleus Capital Management, L.P. increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,459,152 shares valued at US$64.9M — a reduction of -1,089,927 shares quarter over quarter.. Notable position changes include a 877% increase in Q3 2025 (shares rose 14% over the following quarter), a 53% increase in Q4 2025 (shares fell 11% over the following quarter), a 234% increase in Q1 2026 (shares rose 38% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 80.70K | $4.43M | New |
| Q2 2025 | 50.95K | $2.17M | New |
| Q3 2025 | 497.95K | $15.67M | Add |
| Q4 2025 | 764.00K | $27.51M | Add |
| Q1 2026 | 2.55M | $82.00M | Add |
| Q2 2026 | 1.46M | $64.92M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VCEL and 13F data
VCEL (VERICEL CORP) is a Health Care company. 32 other funds we track also report a position in VCEL — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$102.4M), Conestoga Capital Advisors, LLC (US$92.7M), GENEVA CAPITAL MANAGEMENT LLC (US$59.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VCEL
- CONGRESS ASSET MANAGEMENT CO 2.55M sh · $102.44M · Q3 2026
- Conestoga Capital Advisors, LLC 2.08M sh · $92.71M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.34M sh · $59.58M · Q2 2026
- Champlain Investment Partners, LLC 755.83K sh · $33.63M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 612.58K sh · $27.25M · Q2 2026
- SG Capital Management LLC 571.25K sh · $25.42M · Q2 2026
- BROWN CAPITAL MANAGEMENT LLC 504.05K sh · $22.43M · Q2 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held VCEL?
Soleus Capital Management, L.P. has disclosed VCEL holdings in 6 of the last 7 reported quarters, going back to Q4 2024.
What is Soleus Capital Management, L.P.'s current position in VCEL?
As of Q2 2026, Soleus Capital Management, L.P. holds 1.46M shares of VCEL (VERICEL CORP), valued at $64.92M, representing 2.24% of its reported portfolio and ranking #11.
Has Soleus Capital Management, L.P. been buying or selling VCEL?
In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. reduced its position in VCEL. The position peaked in Q1 2026 at 2.55M shares.
Which other funds hold VCEL?
Other major institutional holders of VCEL include CONGRESS ASSET MANAGEMENT CO, Conestoga Capital Advisors, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.